BRAF and colorectal carcinoma: Furthermore, BRAF genotypes were analysed in a large subgroup of 845 metastatic CRC treated with FOLFIRI and FOLFOX chemotherapy with or without cetuximab as the first-line treatment in the CRYSTAL and OPUS studies, respectively (Bokemeyer et al, 2010).